Contact

location_on

48 rue du Président Wilson
59170 Croix
France

Alexandre Fontayne
Président Fondateur

About us

Business offer

Activities

    Categories

    • Service

    Therapeutic applications

    • Cardiology
    • Oncology
    • Nervous Central System
    • Hematology
    • Infectiology
    • Immunology
    • Ophthalmology
    • Inflammation

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Hit discovery
    • Screening & Identification
    • Therapeutic libraries
    • In silico
    • In-vivo models
    • In-vitro & ex-vivo models
    • Immunotherapy lead generation
    • Biophysical profile
    • Binding & Affinity
    • Potency & Specificity
    • Epitope mapping
    • Functional effects
    • ADCC, ADCP & CDC
    • Antigen density target
    • Internalization
    • Pharmacology & Biological activity
    • PK/PD bioavailability
    • Mode of Action
    • Therapeutic efficacy
    • Safety
    • Immunogenicity
    • Hypersensitivity & allergies
    • Immunotoxicology
    • Specificity
    • Manufacturability
    • Production quality
    • CMC feasibility
    • Cell activation
    • Avidity testing
    • Cell-based activation (APCs, AAPCs)
    • Bead-base activation
    • Antibody-based activation
    • Ex-vivo activation (cell transfer)
    • In-vivo activation (in human transgenic mouse models)
    • Immunotherapy lead optimization
    • Engineering
    • Fragments
    • Multi-, bispecific
    • Fc-fusion proteins
    • Antibody humanization
    • Affinity maturation
    • Proof of concept
    • Pharmacology potency
    • Exploratory toxicology
    • in-vitro & ex-vivo models
    • in-vivo models
    • CMC
    • GLP compliance
    • GLP compliance
    • Master Cell Bank
    • Production
    • Cell Line development
    • Clone selection
    • Characterization
    • Storage
    • Analytical development
    • Cell Culture
    • Media composition
    • Bioreactor conditions
    • Gene modification / Transduction
    • Retroviral & lentiviral vectors
    • Cell expansion
    • Wave-mixed bioreactors
    • Stirred tank reactors
    • Bioproduction
    • Batches production type
    • Mammalian
    • Insect
    • Yeast
    • Bacterial
    • GLP compliance
    • GMP compliance
    • Pilot Batches
    • Tests
    • Optimization
    • Scale-Up process
    • Process optimization & validation
    • Volume
    • Preclinical / Tox
    • Low volume (< 200 L)
    • High volume (200 – 2000 L)
    • USP (Scale-Up)
    • Cell expansion
    • Inoculation
    • Low volume containers to Bioreactors
    • DSP (Recovery)
    • Harvest
    • Filtration
    • Purification
    • Fill & Finish
    • Aseptic filling
    • Cell cryopreservation
    • Controlled-rated freezer
    • thaw
    • Quality assurance, quality control & analytical process
    • Stability Assessment
    • Physical & chemical profile
    • Shear/shaking
    • Viscosity
    • Photostability
    • pH
    • Freeze/thaw
    • Heat/degradation
    • Aggregation
    • Cell line analytical development
    • Host cell proteins
    • Viral clearance
    • Contaminants detection
    • Biosafety & Bioanalysis
    • Toxicology
    • PK/PD features
    • Impurities detection
    • Bioproduction analytical test
    • Monitoring
    • Characterization
    • Batch consistency
    • Formulation
    • Formulation
    • Dose
    • Stability
    • Excipients
    • Adjuvants
    • Sterilization
    • Storage stability
    • Delivery
    • Route of Administration
    • Devices associated
Français English